Stock Analysis
- United States
- /
- Packaging
- /
- NasdaqGS:TRS
TriMas Corporation (NASDAQ:TRS) Analysts Are Pretty Bullish On The Stock After Recent Results
TriMas Corporation (NASDAQ:TRS) last week reported its latest quarterly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. Results look mixed - while revenue fell marginally short of analyst estimates at US$229m, statutory earnings were in line with expectations, at US$0.97 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
See our latest analysis for TriMas
Taking into account the latest results, the most recent consensus for TriMas from two analysts is for revenues of US$994.6m in 2025. If met, it would imply a decent 9.7% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to soar 203% to US$1.98. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$963.0m and earnings per share (EPS) of US$2.22 in 2025. While next year's revenue estimates increased, there was also a real cut to EPS expectations, suggesting the consensus has a bit of a mixed view of these results.
Curiously, the consensus price target rose 39% to US$34.12. We can only conclude that the forecast revenue growth is expected to offset the impact of the expected fall in earnings.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting TriMas' growth to accelerate, with the forecast 7.7% annualised growth to the end of 2025 ranking favourably alongside historical growth of 5.8% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 5.5% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect TriMas to grow faster than the wider industry.
The Bottom Line
The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for TriMas. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.
With that in mind, we wouldn't be too quick to come to a conclusion on TriMas. Long-term earnings power is much more important than next year's profits. At least one analyst has provided forecasts out to 2025, which can be seen for free on our platform here.
You still need to take note of risks, for example - TriMas has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about.
Valuation is complex, but we're here to simplify it.
Discover if TriMas might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:TRS
TriMas
Engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide.